Healthy Extracts (HYEX) Short-term Investments (2018 - 2024)

Healthy Extracts' (HYEX) quarterly Short-term Investments came in at $16890.0 in Q4 2024, up 1026.0% quarter-over-quarter from $1500.0 in Q3 2018.

Healthy Extracts (HYEX) Short-term Investments (2018 - 2024) Analysis & Trends

Healthy Extracts' Short-term Investments history runs 2 years deep, the most recent figure standing at $16890.0 for Q4 2024.

On a quarterly basis, Short-term Investments changed N/A year-over-year to $16890.0 in Q4 2024; TTM through Dec 2024 was $16890.0, a N/A change from a year earlier, with the FY2024 full-year figure at $16890.0, changed N/A from the prior year.
Short-term Investments advanced to $16890.0 in Q4 2024 per HYEX's latest filing, from $1500.0 in the prior quarter.
Across five years, Short-term Investments topped out at $16890.0 in Q4 2024 and bottomed at $16890.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Healthy Extracts	14.70 Mn	14.56 Mn	957,429.00

Download Data